VWR Acquires Reliable Biopharmaceutical and BioArra
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/27/2026
- S&P 500 ends lower; chips tumble and Moderna rallies
- SpaceX weighs Starlink mobile service to US consumers, FT reports
- U.S. chip stocks retreat after Apple price hikes stoke fears over AI trade
- Morgan Stanley flags Fed hike risk if unemployment drops below 4%
- UBS trims AI portfolio exposure to semis and hardware after recent rally
VWR (VWR) Tops Q3 EPS by 1c
November 3, 2016 8:59 AM EDTVWR (NASDAQ: VWR) reported Q3 EPS of $0.44, $0.01 better than the analyst estimate of $0.43. Revenue for the quarter came in at $1.14 billion versus the consensus estimate of $1.15 billion.VWR reaffirmed FY2016 guidance.
Acquisition:
VWR also announced the acquisition of two companies, Reliable Biopharmaceutical and BioArra, earlier today.
... More